JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.72B |
| 2 |
Amazon
AMZN
|
+$2.99B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.6B |
| 4 |
Mastercard
MA
|
+$1.47B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.62B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.93B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.95% |
| 2 | Healthcare | 10.56% |
| 3 | Financials | 9.04% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Prestige Consumer Healthcare
PBH
$2.43B
| $11.4M | ﹤0.01% |
199,368
-5,304
| -3% | -$321K |
|
|
CSW
2077
CSW Industrials
CSW
$5.59B
| $11.4M | ﹤0.01% |
65,019
+1,634
| +3% | +$289K |
|
2078
Cytokinetics
CYTK
$10.2B
| $11.4M | ﹤0.01% |
386,101
+11,096
| +3% | +$370K |
|
2079
Medifast
MED
$128M
| $11.4M | ﹤0.01% |
151,964
+8,402
| +6% | +$745K |
|
2080
CALL
Monster Beverage
MNST
$91.4B
| $11.4M | ﹤0.01% |
429,000
+91,600
| +27% | +$2.6M |
|
2081
Kadant
KAI
$3.91B
| $11.3M | ﹤0.01% |
50,237
-4,838
| -9% | -$1.05M |
|
2082
Southwest Gas
SWX
$6.67B
| $11.3M | ﹤0.01% |
187,465
-35,385
| -16% | -$2.26M |
|
2083
Wayfair
W
$13.9B
| $11.3M | ﹤0.01% |
186,871
-412,086
| -69% | -$28.6M |
|
2084
MDU Resources
MDU
$4.27B
| $11.3M | ﹤0.01% |
1,042,832
+97,884
| +10% | +$1.13M |
|
2085
PUT
Biogen
BIIB
$31.1B
| $11.3M | ﹤0.01% |
44,000
+16,800
| +62% | +$4.49M |
|
2086
Resideo Technologies
REZI
$3.1B
| $11.3M | ﹤0.01% |
714,324
+74,239
| +12% | +$1.25M |
|
2087
Nordic American Tanker
NAT
$1.4B
| $11.3M | ﹤0.01% |
2,730,981
+657,300
| +32% | +$2.63M |
|
2088
Encore Capital Group
ECPG
$2.15B
| $11.2M | ﹤0.01% |
235,264
-19,345
| -8% | -$949K |
|
2089
Franklin Electric
FELE
$4.68B
| $11.2M | ﹤0.01% |
125,890
-13,039
| -9% | -$1.26M |
|
2090
LeMaitre Vascular
LMAT
$1.87B
| $11.2M | ﹤0.01% |
205,638
-9,158
| -4% | -$543K |
|
2091
Stride
LRN
$3.48B
| $11.2M | ﹤0.01% |
248,703
-90,952
| -27% | -$3.7M |
|
2092
Scansource
SCSC
$1.06B
| $11.2M | ﹤0.01% |
368,901
+16,188
| +5% | +$485K |
|
|
WBA
2093
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $11.2M | ﹤0.01% |
501,500
+486,200
| +3,178% | +$12.9M |
|
2094
Runway Growth Finance
RWAY
$292M
| $11.1M | ﹤0.01% |
866,506
+156,400
| +22% | +$2.01M |
|
2095
Forward Air
FWRD
$682M
| $11.1M | ﹤0.01% |
161,598
+73,986
| +84% | +$6.51M |
|
2096
Federated Hermes
FHI
$4.74B
| $11.1M | ﹤0.01% |
327,967
-21,206
| -6% | -$730K |
|
2097
PUT
Yum China
YUMC
$16.2B
| $11.1M | ﹤0.01% |
198,900
+184,700
| +1,301% | +$10.3M |
|
|
WCLD
2098
WisdomTree Cloud Computing Fund
WCLD
$319M
| $11.1M | ﹤0.01% |
373,956
+56,907
| +18% | +$1.8M |
|
2099
National Health Investors
NHI
$3.5B
| $11.1M | ﹤0.01% |
215,221
-20,677
| -9% | -$1.08M |
|
2100
PUT
Immunovant
IMVT
$8.64B
| $11M | ﹤0.01% |
+287,500
| New | +$6.5M |
|
Similar funds
JP Morgan Chase's Q3 2023 Portfolio in Review
As of Q3 2023, JP Morgan Chase held 7,912 positions worth $906B, down 1.5% from $920B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
JP Morgan Chase's Q3 2023 filing shows 1,013 new, 2,454 increased, 3,092 reduced and 490 closed positions. Its largest new stake was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.62B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2023 buy was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M.
- JP Morgan Chase added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $3.72B increase.
- JP Morgan Chase's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.62B.
- JP Morgan Chase fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $314M.
- JP Morgan Chase's ten largest holdings make up 19% of its $906B portfolio in Q3 2023.
- JP Morgan Chase opened 1,013 new positions and closed 490 in Q3 2023.
- JP Morgan Chase's portfolio value fell 1.5% quarter-over-quarter to $906B.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.